0001104659-24-070420.txt : 20240611
0001104659-24-070420.hdr.sgml : 20240611
20240611163048
ACCESSION NUMBER: 0001104659-24-070420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240607
FILED AS OF DATE: 20240611
DATE AS OF CHANGE: 20240611
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waddill William D.
CENTRAL INDEX KEY: 0001553338
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 241036228
MAIL ADDRESS:
STREET 1: C/O CALITHERA BIOSCIENCES
STREET 2: 343 OYSTER POINT BLVD, SUITE 200
CITY: SO. SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
tm2416932-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-07
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001553338
Waddill William D.
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560-1160
1
0
0
0
1
Common Stock
2024-06-07
4
M
0
8000
12.88
A
20000
D
Common Stock
2024-06-07
4
S
0
8000
35.00
D
12000
D
Stock Option (right to buy)
12.88
2024-06-07
4
M
0
8000
0.00
D
2026-09-13
Common Stock
8000
16000
D
Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023.
These stock options are fully vested.
/s/ Matthew Gosling, Attorney-in-Fact for William D. Waddill
2024-06-11